Navigation Links
VS II Standalone

ProductsVS II Standalone
Company Roche Diagnostics
Item VS II Standalone
Features VS II system automates those tasks required to generate secondary sample tubes: aliquoting, bar code labeling, sorting and serum tube archiving. It prepares up to 780 tubes per hour for the placement on laboratorys analytical workstations or for the archive. It can be used alone or in combination with other task targeted systems such as the PSD 1 system to provide a customized approach to pre- and post-analytical sample handling. Automates time-consuming sample aliquoting, and sorting. Sorts both primary and secondary tubes with positive sample identification. Decreases the number of sample transfers by sorting directly into Roche/Hitachi 5 position rack, Cobas Core and Cobas Integra racks. Ensures sample integrity with clot detection and low liquid level detection. Separates questionable samples to an exception rack to quickly identify problematic. Reduces the safety risks of handling biological specimens. Reduces the human error associated with manual sample processing and labeling. Up to 780 primary tubes, sorting only, up to 360 primary tubes with one aliquot.
Description The Roche Diagnostics Task Targeted Automation VS II is a state-of-the-art automation of pre- and post-analytical steps in the laboratories: decapping, sorting / archiving of primary tubes and aliquoting into bar code labeled secondary tubes. Fully scalable and extendable to future needs. Works in a standalone mode.
Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. PSD Standalone
2. PDQ Standalone
... effective, non-surgical treatment that works by relaxing ... and smoothing away frown-lines and wrinkles., Dysport ... clinical experience. Dysport was developed in the ... successfully treat a number of neurological and ...
... are dermal fillers approved for the correction ... soft tissue contour deficiencies, as well as ... The collagen in CosmoDerm and CosmoPlast is ... grown under controlled conditions. Based on a ...
... Introduced 18 years ago, Zyderm® and ... standard in filler materials for smoothing facial ... lip border definition. Treatments supplement the skins ... provide immediate results. Today, more than one ...
... is a non-animal stabilized hyaluronic acid-based ... filler to enter the U.S. market. ... moderate to severe facial wrinkles and ... is injected just under the skins ...
Medicine Products:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology: